Primers and method for detecting c.55C>G and c.238C>T site mutation of ATP8B1 gene

A technology of c.55c and ATP8B1-EXON1-R, which is applied in biochemical equipment and methods, recombinant DNA technology, microbial measurement/inspection, etc., can solve the problem of limited number of patients and achieve cost reduction, difficulty and cost High and difficult to detect effects

Pending Publication Date: 2021-04-09
合肥艾迪康医学检验实验室有限公司
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is still a lack of large-sample multi-center epidemiological survey data on the incidence of this disease in my country. Diagnosed children are limited to individual large hospitals in central cities such as Beijing, Shanghai, Guangzhou, and Wuhan. Not only are the number of patients quite limited, but clinical diagnosis and treatment experience It is also necessary to further accumulate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primers and method for detecting c.55C>G and c.238C>T site mutation of ATP8B1 gene
  • Primers and method for detecting c.55C>G and c.238C>T site mutation of ATP8B1 gene
  • Primers and method for detecting c.55C>G and c.238C>T site mutation of ATP8B1 gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] The present invention will be further described below in conjunction with specific embodiments and accompanying drawings. It should be noted that the conventional conditions and methods not described in the examples are generally used by experimenters in the field: for example, the fourth edition of the "Refined Molecular Biology Experiment Guide" edited by Osper and Kingston, Or follow the procedures and conditions recommended by the manufacturer.

[0039] A primer for detecting the c.55C>G, c.238C>T site mutation of the ATP8B1 gene, the primer is a specific amplification product designed for the c.55C>G, c.238C>T site mutation Primers, including:

[0040] Primers for amplifying bases c.55C and c.238 of the ATP8B1 gene, the base sequence of which is:

[0041] ATP8B1-EXON1-F:TGTAAAACGACGGCCAGTTAGGGAGGGAAAAAGGGAG

[0042] ATP8B1-EXON1-R:AACAGCTATGACCATGATCCCGGATCTCCAAAGT

[0043] A kit for detecting the c.55C>G, c.238C>T site mutations of the ATP8B1 gene, comprising ...

Embodiment 2

[0052] Operation process of blood / cell / tissue genomic DNA extraction kit (Tiangen Biology):

[0053] (1) Extract tissue DNA from blood: 1) Extract 300 μl of blood and add 900 μl of erythrocyte lysate, mix by inverting, and place at room temperature for 5 minutes, during which time, invert and mix several times. Centrifuge at 12,000rpm for 1min, suck off the supernatant, leave the white blood cell pellet, add 200μl buffer GA, shake until thoroughly mixed. 2) Add 20 μl proteinase K solution and mix well. 3) Add 200 μl of buffer GB, mix thoroughly by inversion, place at 70°C for 10 minutes, the solution should become clear, and briefly centrifuge to remove water droplets on the inner wall of the tube cap. 4) Add 200 μl of absolute ethanol, vortex and mix well for 15 seconds. At this time, flocculent precipitates may appear. Briefly centrifuge to remove water droplets on the inner wall of the tube cap. 5) Add the solution and flocculent precipitate obtained in the previous step ...

Embodiment 3

[0079] Take 10 cases of clinical peripheral blood samples, extract the genome, prepare reagents and detect according to the method described in Example 2. Add 2 μl of each sample to the detection system PCR reaction solution. At the same time, make positive, negative, and blank controls. After sequencing, it was found that the gene mutation of ATP8B1 c.55 site had mutations in samples 2, 4, and 10, and all other samples had no mutations; ATP8B1c.238 site samples 2 and 10 had mutations, and all other samples had no mutations. The mutation status of samples 1-10 is shown in the table below, and the results of agarose gel electrophoresis are as follows figure 1 As shown, the positive sequencing graph is shown in Figure 2-3 shown.

[0080] c.55C>G c.238C>T 1 - - 2 + + 3 - - 4 + - 5 - - 6 - - 7 - - 8 - - 9 - - 10 + + The detection mutation rate 30% 20% reported mutation rate No report No r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses primers for detecting c.55C>G and c.238C>T base mutation of an ATP8B1 gene. The primers comprise primers for amplifying c.55C>G and c.238C>T sites of the ATP8B1 gene. By adopting a Sanger sequencing technology, the primers can be used for rapidly detecting c.55C>G and c.238C>T site mutation of the ATP8B1 gene in the body of a patient with progressive familial intrahepatic cholestasis type 1. The detection result completed by using the primers is accurate, and the primers have important reference significance for clinical differential diagnosis of the patient with progressive familial intrahepatic cholestasis type 1.

Description

technical field [0001] The invention belongs to the field of life science and biotechnology, in particular to primers for detecting mutations of c.55C>G and c.238C>T sites of ATP8B1 gene, which can be used for rapid detection of progressive familial liver disease by using ordinary PCR combined with Sanger sequencing technology. Mutations of c.55C>G and c.238C>T sites of ATP8B1 gene in patients with type 1 internal cholestasis. Background technique [0002] Progressive familial intrahepatic cholestasis type I (PFIC1), earlier called Byler's disease, is an autosomal recessive genetic disease caused by mutations in the ATP8B1 gene. The ATP8B1 gene is located on chromosome 18q21-22, with a total length of about 176.68 kb, including 28 exons, encoding the FIC1 protein with 1251 amino acid residues. The 7 kb RNA transcript is expressed in most tissues, with abundant expression in pancreas, intestine and liver. ATP8B1 mRNA consists of 3753 coding nucleotides flanked b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883C12Q1/6858C12N15/11
CPCC12Q1/6883C12Q1/6858C12Q2600/156C12Q2531/113C12Q2535/101
Inventor 裘振亚王淑一
Owner 合肥艾迪康医学检验实验室有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products